UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[News Focus] Valsartan chaos reveals Korean drugmakers’ weakness
by So Jae-hyeon
2018-08-13 14:21
Janssen Korea to observe 120 for post-marketing survey of ulcerative colitis treatment
by Lee Hye-seon
2018-08-10 18:25
Pfizer Vitals suffers double-whammy from poor performance, valsartan recall
by So Jae-hyun
2018-08-10 17:56
Cannabinoid group uses blockchain to conduct clinical trials on CBD
by Lee Han-soo
2018-08-10 14:53
Daewoong, Chong Kun Dang compete to develop dementia treatments
by So Jae-hyun
2018-08-09 15:55
라인
JW to launch drug combining Livaro, Ezetimibe
by Lee Hye-seon
2018-08-09 11:59
Competition heats up among Korean Botox makers to develop ‘kDa’
by So Jae-hyeon
2018-08-08 16:53
GSK publishes SWORD data on 2-drug HIV regimen
by Marian Chu
2018-08-08 14:42
Takeda gets approval for antihypertension drug Edarbyclor
by Marian Chu
2018-08-07 17:24
Bukwang registers patients for P2 clinical trial of diabetes treatment
by Lee Han-soo
2018-08-07 17:24
라인
Over 36.8 billion won worth of banned valsartan-based drugs sold last year
by So Jae-hyeon
2018-08-07 15:40
59 Korea-made high blood pressure medications called back over cancer fears
by Marian Chu
2018-08-06 17:50
Chong Kun Dang gets license for generic immunosuppressant
by So Jae-hyeon
2018-08-03 15:38
GC Labcell, AbClon to develop CAR-NK cell treatment
by Lee Han-soo
2018-08-03 14:40
Korean drugmakers rush to establish US subsidiaries
by So Jae-hyeon
2018-08-03 14:40
라인
Genexine, National OncoVenture to develop cervical cancer immunotherapy vaccine
by Lee Han-soo
2018-08-02 17:33
Expert advises against ‘doctor-shopping’ for uveitis treatment
by Marian Chu
2018-08-02 15:37
Pharmacists, convenience store owners in dispute over OTC drugs
by So Jae-hyeon
2018-08-02 15:32
Daewoong Bio’s dementia drug hits 3-digit sales growth
by So Jae-hyeon
2018-08-01 15:50
GC increases in sales but loses profit in Q2
by Lee Han-soo
2018-08-01 15:14
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top